Targeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease

Tiannan Liu1, Enno Klussmann2

  • 1Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

PubMed

Insights

Adenosine 3

Area of Science:

  • Cardiovascular Science
  • Cell Signaling
  • Stem Cell Biology

Background:

  • Adenosine 3',5'-cyclic monophosphate (cAMP) is a crucial second messenger regulating cellular processes.
  • Compartmentalized cAMP signaling is essential for specific cellular responses to stimuli.
  • Human induced pluripotent stem cells (iPSCs) offer significant potential in cardiovascular research.

Purpose of the Study:

  • To review the role of cAMP signaling in iPSC-derived cardiovascular disease models.
  • To explore the utility of these models for understanding disease mechanisms and drug actions.
  • To identify new therapeutic targets for cardiovascular diseases like hypertension and heart failure.

Main Methods:

  • Literature review of studies on cAMP signaling in iPSC-derived cardiovascular models.
  • Analysis of current applications and future prospects of iPSC technology in cardiovascular research.
  • Discussion of therapeutic strategies for cardiovascular diseases.

Main Results:

  • iPSC-derived cardiovascular models provide a platform to study cAMP signaling in disease contexts.
  • These models facilitate drug screening and the identification of novel therapeutic targets.
  • Understanding cAMP signaling in iPSCs can advance precision medicine for cardiovascular conditions.

Conclusions:

  • iPSC-derived cardiovascular models are valuable tools for studying cAMP signaling in cardiovascular diseases.
  • Targeting cAMP pathways in iPSC models holds promise for developing treatments for hypertension and heart failure.
  • This approach supports the advancement of regenerative and precision medicine in cardiology.